BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 7683525)

  • 21. IGF-I differentially regulates IGF-binding protein expression in primary mammary fibroblasts and epithelial cells.
    Fleming JM; Leibowitz BJ; Kerr DE; Cohick WS
    J Endocrinol; 2005 Jul; 186(1):165-78. PubMed ID: 16002546
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of phosphorylation by casein kinase 2 on the activity of insulin-like growth factor-binding protein-3.
    Coverley JA; Martin JL; Baxter RC
    Endocrinology; 2000 Feb; 141(2):564-70. PubMed ID: 10650937
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of human villous trophoblast by insulin-like growth factors and insulin-like growth factor-binding protein-1.
    Hills FA; Elder MG; Chard T; Sullivan MH
    J Endocrinol; 2004 Dec; 183(3):487-96. PubMed ID: 15590975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HER-2/c-erbB2 is phosphorylated by calmodulin-dependent protein kinase II on a single site in the cytoplasmic tail at threonine-1172.
    Feinmesser RL; Gray K; Means AR; Chantry A
    Oncogene; 1996 Jun; 12(12):2725-30. PubMed ID: 8700533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IGF binding proteins and their functions.
    Clemmons DR
    Mol Reprod Dev; 1993 Aug; 35(4):368-74; discussion 374-5. PubMed ID: 7691098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization and hormonal regulation of granulosa cell-derived insulin-like growth factor binding protein-4.
    Choi D; Putowski LT; Fielder PJ; Rosenfeld RG; Rohan RM; Adashi EY
    J Soc Gynecol Investig; 1996; 3(3):145-51. PubMed ID: 8796823
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression and characterization of a serine protease that preferentially cleaves insulin-like growth factor binding protein-5.
    Hou J; Clemmons DR; Smeekens S
    J Cell Biochem; 2005 Feb; 94(3):470-84. PubMed ID: 15534875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phosphorylation of IGFBP-1 at discrete sites elicits variable effects on IGF-I receptor autophosphorylation.
    Abu Shehab M; Iosef C; Wildgruber R; Sardana G; Gupta MB
    Endocrinology; 2013 Mar; 154(3):1130-43. PubMed ID: 23354097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypoxia alters phosphorylation status of insulin-like growth factor (IGF)-binding protein-1 and attenuates biological activities of IGF-I in HepG2 cell cultures.
    Tsunawaki T; Sakai K; Momomura M; Wachi Y; Matsuzawa Y; Iwashita M
    J Obstet Gynaecol Res; 2013 Sep; 39(9):1367-73. PubMed ID: 23815140
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of insulin-like growth factor binding protein-1 kinases from human hepatoma cells.
    Ankrapp DP; Jones JI; Clemmons DR
    J Cell Biochem; 1996 Mar; 60(3):387-99. PubMed ID: 8867814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Site specific phosphorylation of insulin-like growth factor binding protein-1 (IGFBP-1) for evaluating clinical relevancy in fetal growth restriction.
    Abu Shehab M; Inoue S; Han VK; Gupta MB
    J Proteome Res; 2009 Nov; 8(11):5325-35. PubMed ID: 19731965
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endogenous phosphorylation of the lipoprotein-associated coagulation inhibitor at serine-2.
    Girard TJ; McCourt D; Novotny WF; MacPhail LA; Likert KM; Broze GJ
    Biochem J; 1990 Sep; 270(3):621-5. PubMed ID: 2122883
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liver mTOR controls IGF-I bioavailability by regulation of protein kinase CK2 and IGFBP-1 phosphorylation in fetal growth restriction.
    Abu Shehab M; Damerill I; Shen T; Rosario FJ; Nijland M; Nathanielsz PW; Kamat A; Jansson T; Gupta MB
    Endocrinology; 2014 Apr; 155(4):1327-39. PubMed ID: 24437487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phosphorylation of intracellular precursors of human IL-1.
    Kobayashi Y; Appella E; Yamada M; Copeland TD; Oppenheim JJ; Matsushima K
    J Immunol; 1988 Apr; 140(7):2279-87. PubMed ID: 3258335
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin-like growth factor binding protein 1 stimulates cell migration and binds to the alpha 5 beta 1 integrin by means of its Arg-Gly-Asp sequence.
    Jones JI; Gockerman A; Busby WH; Wright G; Clemmons DR
    Proc Natl Acad Sci U S A; 1993 Nov; 90(22):10553-7. PubMed ID: 7504269
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gestational age-dependent expression of insulin-like growth factor-binding protein-1 (IGFBP-1) phosphoisoforms in human extraembryonic cavities, maternal serum, and decidua suggests decidua as the primary source of IGFBP-1 in these fluids during early pregnancy.
    Martina NA; Kim E; Chitkara U; Wathen NC; Chard T; Giudice LC
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1894-8. PubMed ID: 9177402
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serine 209, not serine 53, is the major site of phosphorylation in initiation factor eIF-4E in serum-treated Chinese hamster ovary cells.
    Flynn A; Proud CG
    J Biol Chem; 1995 Sep; 270(37):21684-8. PubMed ID: 7665584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Substitutions for hydrophobic amino acids in the N-terminal domains of IGFBP-3 and -5 markedly reduce IGF-I binding and alter their biologic actions.
    Imai Y; Moralez A; Andag U; Clarke JB; Busby WH; Clemmons DR
    J Biol Chem; 2000 Jun; 275(24):18188-94. PubMed ID: 10766744
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The invariant chain is a phosphorylated subunit of class II molecules.
    Spiro RC; Quaranta V
    J Immunol; 1989 Oct; 143(8):2589-94. PubMed ID: 2507633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phosphorylation of insulin-like growth factor binding proteins.
    Coverley JA; Baxter RC
    Mol Cell Endocrinol; 1997 Apr; 128(1-2):1-5. PubMed ID: 9140069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.